The Proteasome Inhibitor PS-341 in Cancer Therapy by TEICHER, B. A, ARA, G, HERBST, R, PALOMBELLA, V. J, ADAMS, J

Get full text

Acquired Multicellular-Mediated Resistance to Alkylating Agents in Cancer by Kobayashi, Hiroaki, Man, Shan, Graham, Charles H., Kapitain, Sean J., Teicher, Beverly A., Kerbel, Robert S.

Get full text

Antiangiogenic agents potentiate cytotoxic cancer therapies against primary and metastatic disease by TEICHER, B. A, ALVAREZ SOTOMAYOR, E, ZHEN DONG HUANG

Get full text

Cyclooxygenase and lipoxygenase inhibitors in cancer therapy by Ara, G., Teicher, B.A.

Get full text

Preclinical studies of the combination of angiogenic inhibitors with cytotoxic agents by KAKEJI, Y, TEICHER, B. A

Get full text

Malignant cells, directors of the malignant process: role of transforming growth factor-beta by Teicher, B A

Get full text

Hypoxia and drug resistance by Teicher, B A

Get full text

Comparison of several antiangiogenic regimens alone and with cytotoxic therapies in the Lewis lung carcinoma by TEICHER, B. A, HOLDEN, S. A, ARA, G, KORBUT, T, MENON, K

Get full text

Overexpression of Metallothionein Confers Resistance to Anticancer Drugs by Kelley, Susan L., Basu, Alakananda, Teicher, Beverly A., Hacker, Miles P., Hamer, Dean H., Lazo, John S.

Get full text

Oxymetry Deep in Tissues With Low-Frequency Electron Paramagnetic Resonance by Halpern, Howard J., Yu, Cheng, Peric, Miroslav, Barth, Eugene, Grdina, David J., Teicher, Beverly A.

Get full text

Diminished aqueous microviscosity of tumors in murine models measured with in vivo radiofrequency electron paramagnetic resonance by HALPERN, H. J, CHANDRAMOULI, G. V. R, BARTH, E. D, CHENG YU, PERIC, M, GRDINA, D. J, TEICHER, B. A

Get full text

Antitumor activity of cryptophycins: effect of infusion time and combination studies by MENON, K, ALVAREZ, E, FORLER, P, PHARES, V, AMSRUD, T, SHIH, C, AL-AWAR, R, TEICHER, B. A

Get full text

Tumor Resistance to Alkylating Agents Conferred by Mechanisms Operative Only in Vivo by Teicher, Beverly A., Herman, Terence S., Holden, Sylvia A., Wang, Yenyun, Pfeffer, M. Raphael, Crawford, James W., Frei, Emil

Get full text

Optimal scheduling of interleukin 12 and chemotherapy in the murine MB-49 bladder carcinoma and B16 melanoma by TEICHER, B. A, ARA, G, BUXTON, D, LEONARD, J, SCHAUB, R. G

Get full text

TNP-470/minocycline/cytotoxic therapy: A systems approach to cancer therapy by Teicher, B.A., Emi, Y., Kakeji, Y., Northey, D.

Get full text

Paclitaxel/carboplatin administration along with antiangiogenic therapy in non-small-cell lung and breast carcinoma models by HERBST, R. S, TAKEUCHI, H, TEICHER, B. A

Get full text

Antitumor Activity of Anti-CD30 Immunotoxin (Ber-H2/Saporin) In Vitro and in Severe Combined Immunodeficiency Disease Mice Xenografted With Human CD30+ Anaplastic Large-Cell Lympho... by Pasqualucci, Laura, Wasik, Mariusz, Teicher, Beverly A., Flenghi, Leonardo, Bolognesi, Andrea, Stirpe, Fiorenzo, Polito, Letizia, Falini, Brunangelo, Kadin, Marshall E.

Get full text

Transforming growth factor-β in in vivo resistance by TEICHER, B. A, HOLDEN, S. A, ARA, G, CHEN, G

Get full text

Acute in vivo resistance in high-dose therapy by B A Teicher, G Ara, S R Keyes, R S Herbst, E Frei, 3rd

Get full text

A systems approach to cancer therapy. (Antioncogenics + standard cytotoxics-->mechanism(s) of interaction) by Teicher, B A

Get full text